Biology Reference
In-Depth Information
Klinger JR, Thaker S, Houtchens J, Preston IR, Hill NS, Farber HW (2006) Pulmonary hemody-
namic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial
hypertension. Chest 129:417-425
Kodama K, Adachi H (1999) Improvement of mortality by long-term E4010 treatment in mono-
crotaline-induced pulmonary hypertensive rats. J Pharmacol Exp Ther 290:748-752
Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R (1996) Fibrillar collagen inhibits
arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069-1078
Koyama H, Bornfeldt KE, Fukumoto S, Nishizawa Y (2001) Molecular pathways of cyclic nucleo-
tide-induced inhibition of arterial smooth muscle cell proliferation. J Cell Physiol 186:1-10
Lamarche Y, Perrault LP, Maltais S, Tetreault K, Lambert J, Denault AY (2007) Preliminary
experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg 31:
1081-1087
Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC,
Trembath RC (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta
receptor, cause familial primary pulmonary hypertension. Nat Genet 26:81-84
Li M, Sun X, Li Z, Liu Y (2009) Inhibition of cGMP phosphodiesterase 5 suppresses serotonin
signalling in pulmonary artery smooth muscles cells. Pharmacol Res 59:312-318
Lin CS, Chow S, Lau A, Tu R, Lue TF (2001a) Identification and regulation of human PDE5A
gene promoter. Biochem Biophys Res Commun 280:684-692
Lin CS, Chow S, Lau A, Tu R, Lue TF (2001b) Regulation of human PDE5A2 intronic promoter
by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem Biophys Res
Commun 280:693-699
Lobato EB, Beaver T, Muehlschlegel J, Kirby DS, Klodell C, Sidi A (2006) Treatment
with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combi-
nation during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 96:317-322
Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, Morrell NW (2009) Altered bone
morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmo-
nary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and
progression of disease. Circulation 119:566-576
Lu W, Ran P, Zhang D, Peng G, Li B, Zhong N, Wang J (2010) Sildenafil inhibits chronically
hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary
arterial smooth muscle. Am J Physiol Cell Physiol 298:C114-C123
Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd,
Newman J, Williams D, Galie N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris
P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC
(2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmo-
nary hypertension. Am J Hum Genet 68:92-102
Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips
JA 3rd, Soubrier F, Trembath RC, Chung WK (2009) Genetics and genomics of pulmonary
arterial hypertension. J Am Coll Cardiol 54:S32-S42
MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I (1996) 5-Hydroxy-
tryptamine receptors mediating vasoconstriction in pulmonary arteries from control and
pulmonary hypertensive rats. Br J Pharmacol 119:917-930
Maclean MR, Johnston ED, McCulloch KM, Pooley L, Houslay MD, Sweeney G (1997) Phos-
phodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary
hypertension. J Pharmacol Exp Ther 283:619-624
Maurice DH (2005) Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and
cAMP signaling in cells of the cardiovascular system. Front Biosci 10:1221-1228
McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA,
McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J (2009) ACCF/AHA
2009 expert consensus document on pulmonary hypertension a report of the American College
of Cardiology Foundation Task Force on Expert Consensus Documents and the American
Heart Association developed in collaboration with the American College of Chest Physicians;
